Home » Authors » Karen Young

Articles by Karen Young

GenVec To Collaborate With NIH On AIDS Vaccine Development

Jan. 11, 2002

CancerVax Acquiring Cell-Matrix To Complement Cancer Program

Jan. 10, 2002

Renovis Raises $34.3M Privately To Advance Preclinical Programs

Jan. 10, 2002

Renovis Raises $34.3M Privately To Advance Preclinical Programs

Jan. 10, 2002

CancerVax Acquiring Cell-Matrix To Complement Cancer Program

Jan. 10, 2002

3-D Pharma In-Licenses Drug From GSK Through Stock Deal

Jan. 9, 2002

Maxygen Partners With Celltech To Work On Antibody Programs

Jan. 9, 2002

Maxygen Partners With Celltech To Work On Antibody Programs

Jan. 9, 2002

3-D Pharma In-Licenses Drug From GSK Through Stock Deal

Jan. 9, 2002

Alteon Raising $18.6M To Fund Discovery, Development Work

Jan. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.